ONO 8577

Drug Profile

ONO 8577

Latest Information Update: 06 Oct 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ono Pharmaceutical
  • Class Muscle relaxants; Urologics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Overactive bladder

Most Recent Events

  • 13 Apr 2017 Ono Pharmaceutical plans a phase II trial for Overactive bladder in Japan (NCT03106623)
  • 07 Apr 2017 Phase-II clinical trials in Overactive bladder in Japan (PO) (NCT03106623)
  • 02 Feb 2016 Phase-I clinical trials in Overactive bladder in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top